Clinical Trial Update: Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of MEDI-524 in healthy adults; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• MEDI-524

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED